Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Breast Cancer Research : BCR
|
November 26, 2024
Immune landscape of the tumour microenvironment in Ethiopian breast cancer patients
Meron Yohannes, Zelalem Desalegn, Marcus Bauer, et al.
Cancer Research Communications
|
October 28, 2022
Peripheral Blood Monocyte Abundance Predicts Outcomes in Patients with Breast Cancer
Margaret L Axelrod, Yu Wang, Yaomin Xu, et al.
Vaccines
|
November 25, 2023
Comparative Immune Response after Vaccination with SOBERANA<sup>®</sup> 02 and SOBERANA<sup>®</sup> plus Heterologous Scheme and Natural Infection in Young Children
Rocmira Pérez-Nicado, Chiara Massa, Laura Marta Rodríguez-Noda, et al.
Journal for Immunotherapy of Cancer
|
November 17, 2020
Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC
Chiara Massa, Thomas Karn, Carsten Denkert, et al.
Frontiers in Oncology
|
January 6, 2023
Translational analysis and final efficacy of the AVETUX trial - Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer
Joseph Tintelnot, Inka Ristow, Markus Sauer, et al.
Journal for Immunotherapy of Cancer
|
July 28, 2021
PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer
Alexander Stein, Donjete Simnica, Christoph Schultheiß, et al.
Nature Communications
|
September 18, 2020
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Aitziber Buqué, Norma Bloy, Maria Perez-Lanzón, et al.
Geburtshilfe Und Frauenheilkunde
|
July 29, 2022
Update Breast Cancer 2022 Part 1 - Early Stage Breast Cancer
Manfred Welslau, Volkmar Müller, Diana Lüftner, et al.
Nature Communications
|
August 1, 2020
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Aitziber Buqué, Norma Bloy, Maria Perez-Lanzón, et al.
Nature Cancer
|
July 7, 2025
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR<sup>+</sup>HER2<sup>-</sup> breast cancer via CX3CR1<sup>+</sup> macrophages
Giulia Petroni, Claudia Galassi, Kenneth H Gouin, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Breast Cancer Research : BCR
|
November 26, 2024
Immune landscape of the tumour microenvironment in Ethiopian breast cancer patients
Meron Yohannes, Zelalem Desalegn, Marcus Bauer, et al.
Cancer Research Communications
|
October 28, 2022
Peripheral Blood Monocyte Abundance Predicts Outcomes in Patients with Breast Cancer
Margaret L Axelrod, Yu Wang, Yaomin Xu, et al.
Vaccines
|
November 25, 2023
Comparative Immune Response after Vaccination with SOBERANA<sup>®</sup> 02 and SOBERANA<sup>®</sup> plus Heterologous Scheme and Natural Infection in Young Children
Rocmira Pérez-Nicado, Chiara Massa, Laura Marta Rodríguez-Noda, et al.
Journal for Immunotherapy of Cancer
|
November 17, 2020
Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC
Chiara Massa, Thomas Karn, Carsten Denkert, et al.
Frontiers in Oncology
|
January 6, 2023
Translational analysis and final efficacy of the AVETUX trial - Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer
Joseph Tintelnot, Inka Ristow, Markus Sauer, et al.
Journal for Immunotherapy of Cancer
|
July 28, 2021
PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer
Alexander Stein, Donjete Simnica, Christoph Schultheiß, et al.
Nature Communications
|
September 18, 2020
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Aitziber Buqué, Norma Bloy, Maria Perez-Lanzón, et al.
Geburtshilfe Und Frauenheilkunde
|
July 29, 2022
Update Breast Cancer 2022 Part 1 - Early Stage Breast Cancer
Manfred Welslau, Volkmar Müller, Diana Lüftner, et al.
Nature Communications
|
August 1, 2020
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Aitziber Buqué, Norma Bloy, Maria Perez-Lanzón, et al.
Nature Cancer
|
July 7, 2025
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR<sup>+</sup>HER2<sup>-</sup> breast cancer via CX3CR1<sup>+</sup> macrophages
Giulia Petroni, Claudia Galassi, Kenneth H Gouin, et al.
Page
of 5